Breaking News - The Fly

Open Search

IPHA

Innate Pharma

$

()

Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579

IPHA

4/15/2024 - 05:19am

Innate Pharma announces first patient dosed in IPH6501 trial

IPHA

3/6/2024 - 05:39am

Innate Pharma announces Yannis Morel broadens remit to COO

IPHA

1/4/2024 - 05:29am

Innate Pharma announces FDA lifts clinical hold on lacutamab IND

IPHA

1/4/2024 - 05:24am

Fly Intel: Pre-market Movers

CGEN , ALDX , IPHA

…

12/19/2023 - 08:57am

Sanofi exercises option to license NK cell engager program from Innate Pharma

IPHA , SNY

12/19/2023 - 05:12am

Innate Pharma CEO Mondher Mahjoubi resigns, Herve Brailly appointed interim CEO

IPHA

12/18/2023 - 05:27am

Innate announces updated efficacy, safety results from SAR443579 / IPH6101 study

IPHA , SNY

12/11/2023 - 05:27am

Innate Pharma announces partial clinical hold on lacutamab IND placed by FDA

IPHA

10/5/2023 - 05:17am

Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results

IPHA

9/22/2023 - 06:04am

Innate Pharma price target lowered to $8 from $12 at Citi

IPHA

9/18/2023 - 06:46am

Innate Pharma doses first patient in Sanofi-sponsored SAR'514 / IPH6401 trial

IPHA , SNY

7/11/2023 - 05:20am

Innate Pharma announces first patient dosed in MATISSE trial

IPHA , AZN

6/26/2023 - 05:12am

Innate Pharma highlights increased lacutamab activity in TELLOMAK study

IPHA

6/16/2023 - 05:35am

Innate highlights Tetra-specific ANKET NK cell engager IPH6501 at EHA congress

IPHA

6/11/2023 - 06:38am